EIF4G1 抗体
(Eukaryotic Translation Initiation Factor 4 Gamma, 1 (EIF4G1))
The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. [provided by RefSeq, Aug 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| EIF4G1 抗体 (pSer1148) | 人, 小鼠, 大鼠, 兔, Pig | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 1074-1123) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (Middle Region) | 人, 小鼠, 大鼠, 兔, Cow, 马, 豚鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (pSer1108) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (HRP) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Biotin) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Fluoro594) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Fluoro550) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (APC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Cy3) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 497-681) (PE) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (AA 1500-1599) | 人 | 小鼠 Monoclonal |
|
|
|
| EIF4G1 抗体 (AA 1230-1234) | 人 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (Ser1148) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| EIF4G1 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 兔, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- pSer1148
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1074-1123
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow, 马, 豚鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1074-1123, pSer1108
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 497-681
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10C174
- 标记
- unconjugated
- 抗体亚型
- IgG2a kappa
- 抗原表位
- AA 1500-1599
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1230-1234
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Ser1148
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Latest Publications for our EIF4G1 抗体
: "Leucine supplementation stimulates protein synthesis and reduces degradation signal activation in muscle of newborn pigs during acute endotoxemia." in: American journal of physiology. Endocrinology and metabolism, Vol. 311, Issue 4, pp. E791-E801, (2016) (PubMed).
: "Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA." in: Molecular and cellular biology, Vol. 34, Issue 3, pp. 439-51, (2014) (PubMed).
: "Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G." in: Molecular and cellular biology, Vol. 33, Issue 5, pp. 937-46, (2013) (PubMed).
: "Anabolic signaling and protein deposition are enhanced by intermittent compared with continuous feeding in skeletal muscle of neonates." in: American journal of physiology. Endocrinology and metabolism, Vol. 302, Issue 6, pp. E674-86, (2012) (PubMed).
: "A cellular response linking eIF4AI activity to eIF4AII transcription." in: RNA (New York, N.Y.), Vol. 18, Issue 7, pp. 1373-84, (2012) (PubMed).
: "Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Issue 3, pp. 1046-51, (2011) (PubMed).
: "Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1." in: Molecular and cellular biology, Vol. 31, Issue 14, pp. 2947-59, (2011) (PubMed).
: "Intermittent bolus feeding has a greater stimulatory effect on protein synthesis in skeletal muscle than continuous feeding in neonatal pigs." in: The Journal of nutrition, Vol. 141, Issue 12, pp. 2152-8, (2011) (PubMed).
: "Dysregulation of mTOR signaling in fragile X syndrome." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 30, Issue 2, pp. 694-702, (2010) (PubMed).
: "The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection." in: Journal of virology, Vol. 83, Issue 19, pp. 9970-82, (2009) (PubMed).
: "Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA." in: Molecular and cellular biology, Vol. 34, Issue 3, pp. 439-51, (2014) (PubMed).
: "Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G." in: Molecular and cellular biology, Vol. 33, Issue 5, pp. 937-46, (2013) (PubMed).
: "Anabolic signaling and protein deposition are enhanced by intermittent compared with continuous feeding in skeletal muscle of neonates." in: American journal of physiology. Endocrinology and metabolism, Vol. 302, Issue 6, pp. E674-86, (2012) (PubMed).
: "A cellular response linking eIF4AI activity to eIF4AII transcription." in: RNA (New York, N.Y.), Vol. 18, Issue 7, pp. 1373-84, (2012) (PubMed).
: "Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Issue 3, pp. 1046-51, (2011) (PubMed).
: "Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1." in: Molecular and cellular biology, Vol. 31, Issue 14, pp. 2947-59, (2011) (PubMed).
: "Intermittent bolus feeding has a greater stimulatory effect on protein synthesis in skeletal muscle than continuous feeding in neonatal pigs." in: The Journal of nutrition, Vol. 141, Issue 12, pp. 2152-8, (2011) (PubMed).
: "Dysregulation of mTOR signaling in fragile X syndrome." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 30, Issue 2, pp. 694-702, (2010) (PubMed).
: "The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection." in: Journal of virology, Vol. 83, Issue 19, pp. 9970-82, (2009) (PubMed).
Aliases for EIF4G1 抗体
eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) 抗体eukaryotic translation initiation factor 4G (eIF4G) 抗体
eukaryotic translation initiation factor 4 gamma, 1a (eif4g1a) 抗体
eukaryotic translation initiation factor 4 gamma 1 (LOC704923) 抗体
eukaryotic translation initiation factor 4 gamma, 1 S homeolog (eif4g1.S) 抗体
eukaryotic translation initiation factor 4G (EIF4G) 抗体
eukaryotic initiation factor (EIF4G) 抗体
eukaryotic translation initiation factor 4 gamma (eIF4g) 抗体
eukaryotic translation initiation factor 4 gamma (Eif4g) 抗体
eukaryotic translation initiation factor 4 gamma, 1 (Eif4g1) 抗体
eukaryotic translation initiation factor 4, gamma 1 (Eif4g1) 抗体
CG10811 抗体
CUCUMOVIRUS MULTIPLICATION 2 抗体
CUM2 抗体
DDBDRAFT_0217646 抗体
DDBDRAFT_0217647 抗体
DDBDRAFT_0234257 抗体
DDB_0217646 抗体
DDB_0217647 抗体
DDB_0234257 抗体
deIF4G 抗体
Dmel\\CG10811 抗体
E030015G23Rik 抗体
eIF-4G 抗体
EIF-4G1 抗体
EIF4F 抗体
EIF4G 抗体
Eif4G 抗体
eIF4g 抗体
eif4g 抗体
EIF4G1 抗体
EIF4GI 抗体
eIF4GI 抗体
EUKARYOTIC TRANSLATION INITIATION FACTOR 4G 抗体
eukaryotic translation initiation factor 4G 抗体
NV18824 抗体
p200 抗体
P220 抗体
p220 抗体
PARK18 抗体
wu:fb50a05 抗体
wu:fc60b06 抗体
您还需要查找其他产品吗？
You are here:
